Tom Cordiner QC

Ariosa Diagnostics, Inc v Sequenom, Inc [2021] FCAFC 101 (18 June 2021) (infringement and validity of patent concerning pre-natal diagnosis with cell-free fetal DNA);

Janssen Sciences Ireland Unlimited Company v Juno Pharmaceuticals (for hearing in June 2021, settled) (patent infringement and validity regarding darunavir);

Henley Arch Pty Ltd v Henley Constructions Pty Ltd (trial 2021, decision reserved) (trade mark infringement and validity);

Taxiprop Pty Ltd v Neutron Holdings Inc [2020] FCA 1565; [2020] FCA 1822; [2021] FCA 274 (trade mark infringement and validity – LIME for transport services);

CQMS Pty Ltd v ESCO Group LLC [2020] APO 54; [2020] APO 53 (16 December 2020); [2020] APO 24 (22 May 2020); [2020] APO 14 (16 March 2020); [2020] APO 5 (29 January 2020) (opposition to grant of patents regarding method of mining equipment);

Toolgen Incorporated v Fisher (trial 2020 and [2019] FCA 2158 (opposition to first patent for CRISPR gene editing technology);

Henley Arch Pty Ltd v Del Monaco (No.2) [2020] FCCA 1911 (15 July 2020) (house plan copyright infringement);

Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2020] FCAFC 116 (3 July 2020) (patent infringement and validity – fenofibrate);

CQMS Pty Ltd v ESCO Group LLC (16 December 2020) (opposition to grant of patents regarding method of mining equipment);

Regeneron Pharmaceuticals, Inc. v Kymab Limited [2019] APO 36 (31 July 2019) (opposition to patent concerning mouse models for antibody production);

Liberation Developments Pty Ltd v Lomax Group Pty Ltd [2019] FCA 1180 (30 July 2019); [2019] FCA 2059 (5 December 2019) (infringement and validity of patent concerning hoarding systems);

Technological Resources Pty Limited v Tettman [2019] FCA 1889 (15 November 2019) (patent validity for mining equipment);

Sequenom, Inc. v Ariosa Diagnostics, Inc. [2019] FCA 1011 (27 June 2019) (infringement and validity of patent concerning pre-natal diagnosis with cell-free fetal DNA);

InterPharma Pty Ltd v Hospira, Inc (No 5) [2019] FCA 960 (20 June 2019) (infringement and validity of patent concerning drug, dexmedetomidine);

Mylan Health Pty Ltd (formerly BGP Products Pty Ltd) v Sun Pharma ANZ Pty Ltd (formerly Ranbaxy Australia Pty Ltd) (No 2) [2019] FCA 883 (12 June 2019) (costs of patent proceedings re drug, fenofibrate);

Juno Pharmaceuticals Pty Ltd v Millennium Pharmaceuticals, Inc [2019] FCA 526 (16 April 2019) (application to withdraw admission in patent infringement and validity case concerning drug, bortezomib);

Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd (No 2) [2019] FCA 505 (11 April 2019) (interlocutory application for injunction pending appeal);

Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 411 (25 March 2019) (application to set aside notice to produce);

Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd [2019] FCAFC 28 (22 February 2019) (appeal from application for interlocutory injunction re drug dispenser for insulin glargine);

GM Global Technology Operations LLC v S.S.S. Auto Parts Pty Ltd [2019] FCA 97 (11 February 2019) (infringement and validity of design registrations for car parts);

Meat & Livestock Australia Limited v Cargill, Inc (No 2) [2019] FCA 33 (23 January 2019) (opposition to amendment of patent regarding identifying a trait of a bovine subject from a nucleic acid sample);

Mylan Health Pty Ltd (formerly BGP Products Pty Ltd) v Sun Pharma ANZ Pty Ltd (formerly Ranbaxy Australia Pty Ltd) [2019] FCA 28 (22 January 2019) (patent infringement and validity regarding drug, fenofibrate);

Caesarstone Ltd v Ceramiche Caesar S.p.A. (No 3) [2019] FCA 7 (14 January 2019) (trade mark oppositions and revocation for mark CAEARSTONE);

Shen Dian Enterprise Ltd v ARK Corporation Pty Ltd [2018] APO 92 (21 December 2018) (opposition to patent application regarding battery box with built-in charger);

Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd (No 3) [2018] FCA 2060 (19 December 2018) (interlocutory injunction application re patent infringement and validity for drug dispenser for insulin glargine);

Cantarella Bros Pty Ltd v Koninklijke Douwe Egberts B.V. [2018] APO 81 (2 November 2018) (opposition to patent application for coffee capsule systems);

CQMS Pty Ltd. v Esco Group LLC [2018] APO 80 (30 October 2018) and Talon Engineering SDN. BHD. v Esco Group LLC [2018] APO 79 (30 October 2018) (opposition to grant of patent regarding method of shipping wear member of excavating equipment);

Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd (No 2) [2018] FCA 1630 (24 October 2018) (interlocutory injunction application re patent infringement and validity for drug dispenser for insulin glargine);

Reflex Instruments Asia Pacific Pty Ltd v Minnovare Pty Ltd [2018] APO 70 and 71 (22 October 2018) (opposition to grant of patent application for apparatus for orientation of drilling rods using gyroscopes for mining);

Domino's Pizza Enterprises Limited v Precision Tracking Pty Ltd (No 7) [2018] FCA 1160 (8 August 2018) (costs dispute regarding application to amend pleadings in patent infringement and validity and confidential information case concerning pizza tracking systems);

Caesarstone Ltd v Ceramiche Caesar S.p.A. (No 2) [2018] FCA 1096 (31 July 2018) (opposition and cancellation of trade marks);

GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited (No 2) [2018] FCAFC 100 (27 June 2018) (appeal on infringement and validity of patent regarding formulation for paracetamol).